Submission Details
| 510(k) Number | K172322 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2017 |
| Decision Date | March 29, 2018 |
| Days to Decision | 240 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K172322 is an FDA 510(k) clearance for the Atellica IM Total hCG (ThCG), a Visual, Pregnancy Hcg, Prescription Use (Class II — Special Controls, product code JHI), submitted by Siemens Healthcare Diagnostics, Inc. (New York, US). The FDA issued a Cleared decision on March 29, 2018, 240 days after receiving the submission on August 1, 2017. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1155.
| 510(k) Number | K172322 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 01, 2017 |
| Decision Date | March 29, 2018 |
| Days to Decision | 240 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | JHI — Visual, Pregnancy Hcg, Prescription Use |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1155 |